$250 | Single User
$500 | Site License
$750 | Enterprise License

Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017]

Published by Global Data: 20 Jul 2017 | 106796 | In Stock

Introduction

Summary

Alvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company’s product portfolio comprises generic medications in various therapeutic areas that include oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen also focuses on the product development, contract manufacturing and research. It offers products in various forms such as solid oral dosage, modified release tablets, soft gelatin capsules, creams, ointments, transdermals and injectables. The company has operational presence with regional hubs, manufacturing, research and development capabilities in the US, South Korea and Romania. Alvogen is headquartered in Pinebrook, New Jersey, the US.

Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

    Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

    Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

    Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

    Alvogen Inc, Medical Devices Deals, 2011 to YTD 2017 9

    Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

    Alvogen Inc, Pharmaceuticals & Healthcare, Deal Details 11

    Asset Purchase 11

    Alvogen Acquires Five Hormonal Products from Bayer Pharma 11

    Alvogen to Acquire Four Pharma Products from Pfizer 11

    Private Equity 12

    CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 12

    Pamplona Capital Management Acquires Majority Stake In Alvogen 14

    Partnerships 15

    Probi Enters Into Distribution Agreement With Alvogen 15

    Licensing Agreements 15

    Luye Pharma Enters into Licensing Agreement with Lotus Pharma 15

    TMRC Enters Into Licensing Agreement With EPS And Lotus Pharma For TM-411 16

    Asset Transactions 17

    Lotus Pharma Plans to Sell Product Rights 17

    Acquisition 18

    Alvogen to Acquire County Line Pharmaceuticals 18

    Alvogen Acquires Dream Pharma for USD184 Million 19

    Alvogen To Acquire 67% Stake In Lotus Pharma For US5 Million 20

    Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US Million 21

    Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 22

    Alvogen Inc - Key Competitors 24

    Key Employees 25

    Locations And Subsidiaries 26

    Head Office 26

    Other Locations & Subsidiaries 26

    Recent Developments 28

    Strategy And Business Planning 28

    Aug 02, 2016: Alvogen Kicks off in Thailand 28

    Corporate Communications 29

    Jan 13, 2016: Regional management changes to accelerate APAC strategy 29

    Appendix 30

    Methodology 30

    About GlobalData 30

    Contact Us 30

    Disclaimer 30

List Of Tables
in Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017]

List of Tables

Alvogen Inc, Pharmaceuticals & Healthcare, Key Facts 1

Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Alvogen Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Alvogen Inc, Medical Devices Deals, 2011 to YTD 2017 9

Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Alvogen Acquires Five Hormonal Products from Bayer Pharma 11

Alvogen to Acquire Four Pharma Products from Pfizer 11

CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 12

Pamplona Capital Management Acquires Majority Stake In Alvogen 14

Probi Enters Into Distribution Agreement With Alvogen 15

Luye Pharma Enters into Licensing Agreement with Lotus Pharma 15

TMRC Enters Into Licensing Agreement With EPS And Lotus Pharma For TM-411 16

Lotus Pharma Plans to Sell Product Rights 17

Alvogen to Acquire County Line Pharmaceuticals 18

Alvogen Acquires Dream Pharma for USD184 Million 19

Alvogen To Acquire 67% Stake In Lotus Pharma For US5 Million 20

Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US Million 21

Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 22

Alvogen Inc, Key Competitors 24

Alvogen Inc, Key Employees 25

Alvogen Inc, Subsidiaries 26

Additional Details

Publisher

Global Data

Publisher Information

Reference

106796 | GDPH244844D

Number of Pages

30

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAlvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmac...
22 Feb 2017 by Global Data USD $250 More Info
Alvogen Korea Co Ltd (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea Co Ltd (Alvogen), a subsidiary of Alvogen Inc is a pharmaceutical company that ...
13 Jan 2017 by Global Data USD $300 More Info
Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAlvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmac...
21 Nov 2016 by Global Data USD $250 More Info
Alvogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAlvogen, Inc. (Alvogen) is a biopharmaceutical company which develops, manufactures and marke...
29 Jul 2016 by Global Data USD $250 More Info
Alvogen Korea Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea Co., Ltd. (Alvogen), a subsidiary of Alvogen, Inc. is a pharmaceutical company ...
11 Jul 2016 by Global Data USD $300 More Info
Alvogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAlvogen, Inc. (Alvogen) is a biopharmaceutical company which develops, manufactures and marke...
05 May 2016 by Global Data USD $250 More Info
Alvogen Korea Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea (Alvogen) formerly KunWha Pharmaceutical Co., Ltd., a subsidiary of Alvogen, In...
15 Apr 2016 by Global Data USD $300 More Info
Alvogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAlvogen, Inc. (Alvogen) is a biopharmaceutical company which develops, manufactures and marke...
08 Mar 2016 by Global Data USD $250 More Info
Alvogen Korea (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea (Alvogen) formerly KunWha Pharmaceutical Co., Ltd., a subsidiary of Alvogen, In...
09 Jan 2016 by Global Data USD $300 More Info
Alvogen Korea (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea (Alvogen) formerly KunWha Pharmaceutical Co., Ltd., a subsidiary of Alvogen, In...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data